Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives As COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by Molecular Docking and the Swiss ADME Studies. Baghdad Sci.J 2024, 21 (4), 1255. https://doi.org/10.21123/bsj.2023.8295.